{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:59:11Z","timestamp":1780981151382,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.vaccine.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T01:21:06Z","timestamp":1663118466000},"page":"6084-6092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-na\u00efve adults"],"prefix":"10.1016","volume":"40","author":[{"given":"David J.","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Grahek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Elena Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hotez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Bethony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2022.09.017_b0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1756-3305-7-37","article-title":"Global numbers of infection and disease burden of soil transmitted helminth infections in 2010","volume":"7","author":"Pullan","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2022.09.017_b0010","unstructured":"Institute for Health Metrics and Evaluation. Hookworm disease \u2014 Level 4 cause. Global Health Metrics, https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/hookworm-disease-level-4-cause; 2019 [accessed 08 Jan 2022]."},{"issue":"9521","key":"10.1016\/j.vaccine.2022.09.017_b0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(06)68653-4","article-title":"Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm","volume":"367","author":"Bethony","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.017_b0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268800049980","article-title":"A new approach to morbidity risk assessment in hookworm endemic communities","volume":"108","author":"Lwambo","year":"1992","journal-title":"Epidemiol Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.017_b0025","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0020067","article-title":"Hookworm: \u201cthe great infection of mankind\u201d","volume":"2","author":"Hotez","year":"2005","journal-title":"PLoS Med"},{"issue":"19","key":"10.1016\/j.vaccine.2022.09.017_b0030","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.vaccine.2016.03.018","article-title":"Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting","volume":"34","author":"Bartsch","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.017_b0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1086\/524070","article-title":"Hookworm vaccines","volume":"46","author":"Diemert","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.017_b0040","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1473-3099(06)70630-2","article-title":"Hookworm vaccines: past, present, and future","volume":"6","author":"Loukas","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.017_b0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/597048","article-title":"Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus","volume":"199","author":"Ranjit","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.017_b0050","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1096\/fj.02-0181fje","article-title":"Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity","volume":"16","author":"Williamson","year":"2002","journal-title":"Faseb J"},{"issue":"3","key":"10.1016\/j.vaccine.2022.09.017_b0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/367708","article-title":"Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion","volume":"187","author":"Williamson","year":"2003","journal-title":"J Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2022.09.017_b0060","doi-asserted-by":"crossref","first-page":"35950","DOI":"10.1074\/jbc.M405842200","article-title":"A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms","volume":"279","author":"Williamson","year":"2004","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.017_b0065","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1371\/journal.pmed.0020295","article-title":"Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs","volume":"2","author":"Loukas","year":"2005","journal-title":"PLoS Med"},{"issue":"9","key":"10.1016\/j.vaccine.2022.09.017_b0070","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1096\/fj.09-131433","article-title":"An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection","volume":"23","author":"Pearson","year":"2009","journal-title":"Faseb J"},{"issue":"6","key":"10.1016\/j.vaccine.2022.09.017_b0075","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1080\/21645515.2015.1036207","article-title":"Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine","volume":"11","author":"Seid","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"14","key":"10.1016\/j.vaccine.2022.09.017_b0080","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2013.01.042","article-title":"Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines","volume":"31","author":"Tavares Da Silva","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.017_b0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(20)30288-7","article-title":"Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial","volume":"21","author":"Adegnika","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.09.017_b0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2012.04.027","article-title":"Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths","volume":"130","author":"Diemert","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.09.017_b0095","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1586\/erv.10.107","article-title":"Potency testing for the experimental Na-GST-1 hookworm vaccine","volume":"9","author":"Jariwala","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2022.09.017_b0100","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.trstmh.2006.05.012","article-title":"Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil","volume":"101","author":"Brooker","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.vaccine.2022.09.017_b0105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/344268","article-title":"Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People\u2019s Republic of China","volume":"35","author":"Bethony","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2022.09.017_b0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0169-4758(87)90060-3","article-title":"Do hookworms elicit protective immunity in man?","volume":"3","author":"Behnke","year":"1987","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2022.09.017_b0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.femsim.2004.11.006","article-title":"Immunobiology of hookworm infection","volume":"43","author":"Loukas","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"17-19","key":"10.1016\/j.vaccine.2022.09.017_b0120","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1016\/S0264-410X(00)00520-X","article-title":"The prevention of Lyme disease with vaccine","volume":"19","author":"Poland","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2022.09.017_b0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/clinids\/6.4.567","article-title":"Lipid A and immunotherapy","volume":"6","author":"Ribi","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.09.017_b0130","doi-asserted-by":"crossref","first-page":"e0005574","DOI":"10.1371\/journal.pntd.0005574","article-title":"Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults","volume":"11","author":"Diemert","year":"2017","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22011136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:28Z","timestamp":1759403968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22011136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":26,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0264410X22011136"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-na\u00efve adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}